SCM
INBX

Soleus Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Soleus Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-267,871
Closed -$9.36M – 116
2024
Q1 		$9.36M Buy
267,871
+252,871
+1,686% +$9.22M 0.7% 43
2023
Q4 		$570K Sell
15,000
-534,183
-97% -$11.4M 0.06% 65
2023
Q3 		$10.1M Buy
549,183
+76,000
+16% +$1.59M 0.93% 35
2023
Q2 		$12.3M Buy
473,183
+35,181
+8% +$822K 1.37% 21
2023
Q1 		$8.27M Sell
438,002
-40,300
-8% -$937K 0.86% 32
2022
Q4 		$11.8M Buy
478,302
+114,400
+31% +$3.36M 1.69% 22
2022
Q3 		$6.53M Buy
+363,902
New +$6.56M 0.89% 34
2021
Q4 		– Sell
-97,979
Closed -$3.26M – 94
2021
Q3 		$3.26M Sell
97,979
-144,810
-60% -$4.41M 0.51% 47
2021
Q2 		$6.68M Sell
242,789
-158,704
-40% -$3.3M 1.03% 24
2021
Q1 		$8.06M Buy
401,493
+187,686
+88% +$5.48M 1.45% 14
2020
Q4 		$7.05M Sell
213,807
-192,693
-47% -$5.13M 0.93% 14
2020
Q3 		$7.32M Buy
+406,500
New +$7.37M 3.88% 5

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Soleus Capital Management's INBX Position: Q2 2024 in Review

Soleus Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 267,871 shares — an estimated $9.36M sold.

Soleus Capital Management first reported a position in INBX in Q3 2020 and held it in 12 quarters. The position peaked at $12.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Soleus Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Soleus Capital Management sold 267,871 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $9.36M.
  • Soleus Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Soleus Capital Management's Inhibrx, Inc. Common Stock position peaked at $12.3M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Soleus Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.